Correct answer: A) Acute pancreatitis✅
Key Clinical Clue in the Image
The patient is leaning forward on knees with the trunk flexed (similar to the knee-chest or leaning forward position).
Patients with acute pancreatitis often obtain pain relief by sitting up and leaning forward.
Why This Happens
Acute pancreatitis causes severe epigastric pain radiating to the back because the pancreas is retroperitoneal.
When the patient leans forward:
Pressure on the inflamed pancreas decreases
Stretch on retroperitoneal nerves reduces
Pain intensity improves
Thus patients instinctively adopt this forward-bending posture.
Typical Clinical Features of Acute Pancreatitis
Severe epigastric pain
Pain radiating to the back
Nausea and vomiting
Pain worse when lying supine
Relieved by sitting or leaning forward
Associated lab findings:
↑ Serum amylase
↑ Serum lipase
Why the Other Options Are Incorrect
B) Acute appendicitis
Appendicitis
Typical features:
Pain starts periumbilical → migrates to RLQ
McBurney’s point tenderness
Pain worsens with movement
No relief with leaning forward.
C) Acute cholecystitis
Cholecystitis
Typical features:
Right upper quadrant pain
Murphy sign positive
Pain after fatty meals
May radiate to right shoulder
Position change usually does not relieve pain.
D) GERD
Gastroesophageal reflux disease
Typical features:
Heartburn
Worse when lying down
Regurgitation
But severe abdominal pain relieved by leaning forward is not typical.
✅ Final Answer: A) Acute pancreatitis – because pancreatic pain classically improves when the patient leans forward or sits upright.
@drsthanus Ring worm (tinea infection of the trunk) characterised by ring like skin lession itchy can be multiple the treatment is using topical antifungal agent ketoconazole cream and po griseafluvin
KDIGO relaeses 2026 Clinical Practice Guideline for the Management of Anemia in CKD updating the 2012 guideline.
📌 Key Recommendation Summaries👇
1) Diagnosis & Evaluation of Anemia
Screen all CKD patients for anemia at referral, with repeated testing during follow-up based on disease stage.
Diagnostic tests should include:
-CBC (complete blood count)
-Reticulocyte count
-Ferritin
-Transferrin saturation (TSAT)
Evaluate for other causes of anemia (e.g., iron deficiency, blood loss, inflammation).
---
2) Iron Therapy Recommendations
Assess iron status before starting anemia therapy in CKD (not just hemoglobin).
Iron therapy can be given orally or intravenously, chosen based on:
-CKD stage
-Symptoms
-Tolerance and response to prior therapy
IV iron is often preferred in people on dialysis or with more severe deficiency.
Iron should be used to raise iron stores and support erythropoiesis before/alongside other agents.
---
3) Use of Erythropoiesis-Stimulating Agents (ESAs)
ESAs are recommended for patients with symptomatic anemia after iron status has been optimized.
Target hemoglobin should be individualized, avoiding high hemoglobin targets that may increase cardiovascular risk.
ESA therapy decisions should balance:
-Quality-of-life benefits
-Risks (e.g., hypertension, thrombosis)
-Monitor hemoglobin regularly to adjust ESA dosing.
---
4) Hypoxia-Inducible Factor Prolyl-Hydroxylase Inhibitors (HIF-PHIs)
Recognized as alternative treatments to ESAs in appropriate patients.
-Considered for people who:
-Cannot tolerate ESAs
-Have ESA hyporesponsiveness
Long-term safety and comparative outcomes with ESAs are still being defined.
---
5) Red Blood Cell (RBC) Transfusion Guidance
Transfusions are NOT first-line therapy for anemia in CKD.
Limited to:
-Severe symptomatic anemia
-Life-threatening situations
Risks of transfusion (e.g., immune sensitization, volume overload) should be weighed carefully.
---
6) Special Populations
Children, transplant recipients, and dialysis patients have specific considerations in anemia management (tests and targets may vary).
e.g., children may have age-specific hemoglobin thresholds.